Viewing StudyNCT00431210



Ignite Creation Date: 2024-05-05 @ 5:20 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00431210
Status: COMPLETED
Last Update Posted: 2017-04-18
First Post: 2007-02-02

Brief Title: Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-02
Start Date Type: None
Primary Completion Date: 2015-06-30
Primary Completion Date Type: ACTUAL
Completion Date: 2016-01-26
Completion Date Type: ACTUAL
First Submit Date: 2007-02-02
First Submit QC Date: February 2 2007
Study First Post Date: 2007-02-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-04-14
Last Update Post Date: 2017-04-18
Last Update Post Date Type: ACTUAL